- Home
- RSG vs TAK Comparison
RSG vs TAK Comparison
Compare RSG & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RSG | TAK |
|---|---|---|
| Founded | 1996 | 1781 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.1B | 59.8B |
| IPO Year | 1998 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RSG | TAK |
|---|---|---|
| Price | $246.36 | $20.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 27 | 3 |
| Target Price | ★ $256.00 | $22.99 |
| AVG Volume (30 Days) | 1.3M | ★ 2.9M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | 1.07% | ★ 1.14% |
| EPS Growth | ★ 5.55 | N/A |
| EPS | ★ 5.47 | N/A |
| Revenue | ★ $19,027,000,000.00 | N/A |
| Revenue This Year | $5.32 | $4.46 |
| Revenue Next Year | $4.84 | $2.11 |
| P/E Ratio | $44.86 | ★ $41.25 |
| Revenue Growth | ★ 3.31 | N/A |
| 52 Week Low | $196.41 | $13.56 |
| 52 Week High | $249.37 | $21.22 |
Technical Indicators
Market Signals| Indicator | RSG | TAK |
|---|---|---|
| Relative Strength Index (RSI) | 65.94 | 67.33 |
| Support Level | $202.16 | $17.73 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 5.55 | 0.37 |
| MACD | 0.85 | 0.06 |
| Stochastic Oscillator | 69.38 | 65.62 |
Price Performance
Historical ComparisonAbout RSG Republic Services Inc.
Republic Services Group is the second-largest waste management company by revenue and provides integrated waste management services to residential, commercial, and industrial customers. With 208 active landfills, 248 transfer stations, and 75 recycling centers, Republic Services has reached $16 billion in annual revenue, focusing on recycling and environmental solutions. The company reports in three segments based on the Western United States (Group 1), Eastern United States (Group 2), and Environmental Solutions across North America (Group 3). Eighty-nine percent of total revenue comes from recycling and waste, with the remaining 11% from Environmental Solutions.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.